IcahnWebV

Predatory Icahn moves in on weakened Genzyme

February 23, 2010
Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …

Avandia

Reports raise fresh Avandia safety questions

February 23, 2010
Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …

Baroness Thornton joins the Department of Health

February 23, 2010
DH, UK, appointment

Baroness Thornton has been appointed parliamentary under-secretary of state at the Department of Health. Prior to this she was government …

Pfizer, Lilly and Merck partner for cancer research

February 23, 2010
Research and Development Asia, Cancer, developing world, em, emerging markets

Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …

Digital Pharma: Searching for clinical trials

February 23, 2010
Research and Development CRO, TrialReach, digi, digital pharma, digital pharma research, digital research, patient recruitment

A new clinical trials search and referral engine has launched to help patients who are considering taking part in a …

Shire readies Gaucher drug Vpriv

February 23, 2010
Manufacturing and Production Cerezyme, Gaucher's, Shire, Vpriv

Shire Pharmaceuticals says it has already manufactured enough of its Vpriv to treat around 400 Gaucher disease patients and could …

Lilly UK appoints Ramona Sequeira managing director

February 23, 2010
Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing

Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …

Shire's Adderall

Low Adderall sales hit Shire

February 22, 2010
Sales and Marketing 2009 financials, Adderall, Shire

Shire has posted negative growth due to generic competition for its flagship ADHD drug Adderall XR. Product sales were down …

Brain picture

Novartis gains edge in MS treatment race

February 22, 2010
Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …

Sanofi’s Humenza poised to be Europe’s fifth swine flu vaccine

February 22, 2010
Sales and Marketing Sanofi Pasteur, Tyverb, Zeftera, swine flu

Sanofi Pasteur’s Humenza is set to become the fifth swine flu vaccine in Europe after gaining the support of a …

Taro will close Irish facility next month

February 22, 2010
Manufacturing and Production Sun Pharma, Taro Pharma, manufacturing and production

Israeli drugmaker Taro Pharma has decided to halt manufacturing at a plant in Tipperary, Ireland, resulting in the loss of …

RTS Life Science Appoints Richard Carpenter

February 22, 2010
Manufacturing and Production appointment, manufacturing and production, rts life science

RTS Life Science has expanded its US field-based sales team, appointing Richard Carpenter Mid-Atlantic sales manager.  The company, which supplies …

ReNeuron to begin landmark stem cell trial for stroke

February 19, 2010
Research and Development ReNeuron, stem cell

ReNeuron has been given the go-ahead to begin clinical trials of the first ever stem cell therapy for patients disabled …

UK contractor Excelsyn sold to AMRI

February 19, 2010
Manufacturing and Production AMRI, Excelsyn

UK contract development and manufacturing services company Excelsyn has been bought for $19 million by US rival AMRI, which said …

Pharma manufacturing news in brief

February 19, 2010
Manufacturing and Production AMPAC Fine Chemicals, Avrio, Haupt Pharma, NeoStem

German contract manufacturing organisation (CMO) Haupt Pharma said its site in Latina, Italy, has passed an FDA inspection. Following the …

77 million Europeans fuelling counterfeits market

February 19, 2010
Sales and Marketing Europe, Pfizer, counterfeits

A new survey commissioned by Pfizer shows that Europeans are fuelling a counterfeit medicines market worth €10.5 billion.The findings are …

Tracleer1

Tracleer continues to fuel Actelion growth

February 19, 2010
Sales and Marketing Actelion, Tracleer

Actelion has posted a 20% increase in revenue on the strength of its pulmonary hypertension treatment Tracleer. The drug saw …

Rituxan gains approval for most common leukaemia

February 19, 2010
Sales and Marketing FDA, MabThera, Rituxan, blood cancer

Roche’s blockbuster cancer treatment MabThera/Rituxan has been approved by the FDA for the treatment of adult leukaemia. The drug earned …

Clinipace appoints Bud Owen and Daryl Porter

February 19, 2010
Research and Development Clinipace, appointment, research and development

CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has …

The Gateway to Local Adoption Series

Latest content